These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1505649)

  • 1. Atherogenic profiles in insulin-dependent diabetic patients and their treatment.
    De Leeuw I
    Eur J Epidemiol; 1992 May; 8 Suppl 1():125-8. PubMed ID: 1505649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.
    Krentz AJ
    Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S19-27. PubMed ID: 14984018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience. The DCCT Research Group.
    Diabetes Care; 1992 Jul; 15(7):886-94. PubMed ID: 1516509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
    Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
    Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pancreas transplantation on distribution and composition of plasma lipoproteins.
    Föger B; Königsrainer A; Palos G; Ritsch A; Tröbinger G; Menzel HJ; Lechleitner M; Doblinger A; König P; Utermann G; Margreiter R; Patsch JR
    Metabolism; 1996 Jul; 45(7):856-61. PubMed ID: 8692021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.
    Laakso M; Pyörälä K
    Atherosclerosis; 1988 Nov; 74(1-2):55-63. PubMed ID: 3214481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
    Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
    Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of dyslipidemia in adults with diabetes.
    Haffner SM
    Diabetes Care; 1998 Jan; 21(1):160-78. PubMed ID: 9538988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
    Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
    Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic dyslipidaemia.
    Erkelens DW
    Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
    Demant T
    Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very low density lipoprotein. Qualitative abnormalities in patients with premature coronary heart disease and in patients with insulin dependent diabetes.
    Mancini M; Pauciullo P; Cortese C; Rubba P; Riccardi G; Rivellese A
    Horm Metab Res Suppl; 1988; 19():13-5. PubMed ID: 3235056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of large low density lipoprotein particles and lower fractional esterification rate of cholesterol in high density lipoprotein in children with insulin-dependent diabetes mellitus.
    Ohta T; Nishiyama S; Nakamura T; Saku K; Maung KK; Matsuda I
    Eur J Pediatr; 1998 Apr; 157(4):276-81. PubMed ID: 9578960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Residual risk: The roles of triglycerides and high density lipoproteins].
    Grammer T; Kleber M; Silbernagel G; Scharnagl H; März W
    Dtsch Med Wochenschr; 2016 Jun; 141(12):870-7. PubMed ID: 27305303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.